Sookaromdee, P., & Wiwanitkit, V. (2021). Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationSookaromdee, Pathum, and Viroj Wiwanitkit. Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem. Wolters Kluwer Medknow Publications, 2021.
MLA (8th ed.) CitationSookaromdee, Pathum, and Viroj Wiwanitkit. Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem. Wolters Kluwer Medknow Publications, 2021.
Warning: These citations may not always be 100% accurate.